• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Our Services
  • Contact Us
  • Newsletter
  • Top Nav Social Icons

FindBiometrics

FindBiometrics

Global Identity Management

  • Biometrics
    • What are Biometrics?
    • FAQ
    • Biometric Associations
    • Companies
    • Premier Partners
  • News
    • Featured Articles
    • Interviews
    • Thought Leadership
    • Podcasts
    • Webinars
    • Year in Review
  • Applications
    • Biometric Security
    • Border Control and Airport Biometrics
    • Consumer and Residential Biometrics
    • Financial Biometrics
    • Fingerprint & Biometric Locks
    • Healthcare Biometrics
    • Justice and Law Enforcement Biometrics
    • Logical Access Control Biometrics
    • Mobile Biometrics
    • Other Biometric Applications
    • Physical Access Control Biometrics
    • Biometric Time and Attendance
  • Solutions
    • Behavioral Biometrics
    • Biometric Sensors and Detectors
    • Facial Recognition
    • Biometric Fingerprint Readers
    • Hand Readers & Finger Scanners
    • Iris Recognition
    • Biometric Middleware and Software
    • Multimodal Biometrics
    • Physiological Biometrics
    • Smart Cards
    • Vein Recognition
    • Voice and Speech Recognition
  • Stocks
  • Events
  • Directory
  • Podcasts

Veristat Eyes European Market With Acquisition of SQN Clinical

February 25, 2021

Veristat is looking to raise its international profile through the acquisition of SQN Clinical. Both companies are Clinical Research Organizations (CRO) that help other healthcare organizations conduct clinical trials and bring new solutions to market more quickly.

Veristat Eyes European Market With Acquisition of SQN Clinical

However, the two companies do have different areas of focus within the CRO field. Veristat is best known for its work in novel drug development in the pharmaceutical industry, while SQN specializes in biometric solutions for the European market.

It is that biometric expertise that motivated Veristat to pursue the acquisition. The company believes that adding SQN to its portfolio will bolster its own biometric capabilities, and give Veristat the ability to take on a broader range of projects. It will also allow the company to take on more projects, since Veristat will be adding more than 100 SQN employees to its roster.

Those new employees are based in Europe, so Veristat is hoping that the acquisition will give it more reach in that region in particular. The company noted that Europe has a stricter regulatory ecosystem, and is planning to leverage its own submission expertise to help its clients navigate that environment.

“The joining of our organizations enables Veristat to address the needs of our European and global customers conducting trials in the US, UK and throughout Europe,” said Veristat Europe VP Montse Barceló Riera. “SQN Clinical enhances Veristat’s biometrics capabilities across the continent to proactively address the increased demand from sponsors.”

“Enriching analytical insight and working as a true partner with our clients to reduce the time and cost burdens of clinical trials and improve their results has always been a foundational goal,” added SQN Director Karen Grover. “We have a reputation for scientific excellence and a shared passion for teamwork to support consistent service delivery and high quality outcomes.”

Veristat will be hoping to capture a portion of a growing biometric healthcare market. Visiongain has predicted that that market will reach $14.65 billion by 2028, while Grand View Research places it at $14.5 billion in 2025. However, it is worth noting that both of those forecasts predate the COVID-19 pandemic, which has generated more interest in remote and home healthcare solutions. 

–

February 25, 2021 – by Eric Weiss

Related News

  • Imprivata Enhances Biometric Patient ID Platform with ML Analytics via FairWarning AcquisitionImprivata Enhances Biometric Patient ID Platform with ML Analytics via FairWarning Acquisition
  • Sonde Health Expands Voice ‘Biomarker’ Database with NeuroLex AcquisitionSonde Health Expands Voice ‘Biomarker’ Database with NeuroLex Acquisition
  • Pindrop Expands Security Portfolio With Next Caller AcquisitionPindrop Expands Security Portfolio With Next Caller Acquisition
  • Uniphore Enters Video Analytics Market With Emotion Research Labs AcquisitionUniphore Enters Video Analytics Market With Emotion Research Labs Acquisition
  • NEC Completes Acquisition of Swiss Wealth Management SpecialistNEC Completes Acquisition of Swiss Wealth Management Specialist
  • Acquisition Brings AFIX Biometric Solutions to Aware PortfolioAcquisition Brings AFIX Biometric Solutions to Aware Portfolio

Filed Under: News Tagged With: acquisitions, Biometric, biometrics, Clinical Research Organizations, clinical trials, Europe, healthcare biometrics, mergers and acquisitions, SQN Clinical, Veristat

Primary Sidebar

IDEMIA big box

Register For Our Upcoming Event:

Iris ID

Sponsored Links

AU10TIX, an identity management company headquartered in Israel, provides critical, modular solutions to link physical and digital identities so that companies and their customers can confidently connect.

CMITech is a leading provider of high performance, cost effective iris recognition systems. The company is setting the industry standard for advanced user interfaces that are fast, intuitive and effortless. Serving enrollment and authentication solutions of all sizes, CMITech systems include binoculars-type, wall mount, desktop, and kiosk-type product configurations.

Onfido is building the new identity standard for the internet.Our AI-based technology assesses whether a user’s government-issued ID is genuine or fraudulent, and then compares it against their facial biometrics. That’s how we give companies like Revolut, Zipcar and Bitstamp the assurance they need to onboard customers remotely and securely. Our mission is to create a more open world, where identity is the key to access.. For more information, please visit
www.onfido.com
TECH5 is an international technology company headquartered in Geneva, Switzerland, with branches in the US, Europe and Asia, dedicated to the design, development, and distribution of biometrics-driven Identity Management solutions. Target markets include Government and Private sectors with products powering Civil ID, Digital ID, eKYC, Digital Onboarding, Visitor Management and others. Learn more:
www.tech5.ai
ThreatMark brings trust to the digital world by providing cutting-edge fraud prevention solutions. Major banks use ThreatMark's AI-powered technology and behavioral biometrics to build secured banking experience to precisely verify their legitimate users, seamlessly across all digital channels. All while securing the users' most precious assets and keeping the fraudsters away. Learn more:
www.threatmark.com/
NEC IDelight
MobileIDWorld

Mobile ID World is here to bring you the latest in mobile authentication solutions and application providers. Our company is dedicated to providing users with the best content and cutting edge information on technology, news, and mobile solutions for your mobile identity management needs.

Aware ABIS webinar

Recent Posts

  • Corporate Moves and Face Biometrics: This Week’s Top Stories
  • KONA I Receives Mastercard Letter of Approval for Payment Card Featuring Precise Biometrics
  • BONAFiDEE Upgrades Identity Verification Solution With Active Liveness Detection
  • Vision-Box Extends Biometric Screening Contract With Sint Maarten Airport
  • Keyless Rides New Partnerships to Another $3 Million in Seed Funding

Biometric Associations

IBIA and fido
Iris ID

Tweets

Footer

  • About Us
  • Company Directory
  • Advertise With Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Archives

Follow Us

Copyright © 2021 FindBiometrics